← Evidence map

ReviewF1000Research2019

RANKL is a therapeutic target of bone destruction in rheumatoid arthritis.

Sakae TanakaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31069051